Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo
Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
05/2003
05/08/2003US20030086873 For imaging body tissues; radiopharmaceutical
05/08/2003US20030086870 Methods for detecting lesions in dense breast tissue using LHRH antagonists
05/08/2003US20030086868 Actinium-225 complexes and conjugates for radioimmunotherapy
05/08/2003US20030086867 Blood clot-targeted nanoparticles
05/07/2003EP1308481A2 Metal-mediated cross-coupling with ring-metalated porphyrins
05/07/2003EP1307486A2 Somatostatin analogues
05/07/2003EP1307446A1 Perfluoroalkyl-containing complexes comprising sugar residues, method for producing the same and use thereof
05/07/2003EP1307240A2 Radiolabelled metal transport protein as imaging agent
05/07/2003EP1307239A1 Radiopharmaceutical for diagnostic imaging containing a technetium-99m nitride heterocomplex
05/07/2003EP1307237A2 Complexes containing perfluoroalkyl with polar radicals, method for the production and use thereof
05/07/2003EP1307226A2 Vitronectin receptor antagonist pharmaceuticals
05/07/2003EP1263447A4 Optically-active nanoparticles for use in therapeutic and diagnostic methods
05/07/2003EP0949265B1 Radioactive transition metal nitride hetero-complex
05/07/2003EP0665729B1 Biocompatible polymers containing diagnostic or therapeutic moieties
05/07/2003EP0627940B1 Use of immunoconjugates for the diagnosis and/or therapy of vascularized tumors
05/06/2003US6559315 Phenyl- and pyridyl-substituted thiazoline acid derivatives useful in diagnosing and treating pathological conditions associated with an excess of trivalent metals in humans and animals.
05/06/2003US6558669 Aminopolycarboxylate appended peptide
05/06/2003US6558650 Enhancement of cellular gallium uptake
05/06/2003US6558649 Vitronectin receptor antagonist pharmaceuticals
05/06/2003CA2109208C Radiolabeled metal-binding protein for the treatment of arthritis
05/06/2003CA2082160C Humanised and chimeric monoclonal antibodies
05/03/2003WO2003022863A1 Secreted and cell surface genes expressed in benign and malignant colorectal tumors
05/02/2003EP1306095A2 Methods and compositions for targeting the vasculature of solid tumors
05/02/2003EP1306085A1 2-Cyclohexyl-4-phenyl-1H-imidazole derivatives as ligands for the neuropeptide Y5 receptor
05/02/2003EP1305425A2 Drug metabolizing enzymes
05/02/2003EP1305342A2 Human kininogen d5 domain polypeptides and their use
05/02/2003EP1305051A2 Targeted delivery of cytotoxic drugs a) to activated lymphocytes in patients with transplanted organs, b) as radiosensitizers to cancer cells in patients undergoing radiation therapy, and c) in vitamin-binding proteins as drug carriers in the diagnosis and treatment of cancer
05/02/2003EP1305045A1 Treatment of b cell malignancies using combination of b cell depleting antibody and immune modulating antibody related applications
05/02/2003EP1212103A4 4-fluoroalkyl-3-halophenyl nortropanes
05/02/2003EP0988035B1 Caspases and apoptosis
05/02/2003EP0706396B1 1,2,3,4-tetrahydroquinoline-2,3,4-trione-3 or 4-oximes and use
05/02/2003EP0674710B1 Peptides with broad neoplastic specificity
05/01/2003WO2003035114A1 Radiopharmaceutical agent for the treatment of early stage cancer
05/01/2003WO2003034903A2 Psma antibodies and protein multimers
05/01/2003WO2002100336A3 Tissue-specific endothelial membrane proteins
05/01/2003WO2002098897A3 Modified antibodies to prostate-specific membrane antigen and uses thereof
05/01/2003WO2002092005A3 Stabilization of radionuclide-containing compositions
05/01/2003US20030083494 Porphyrins containing multiple carborane cages which selectively accumulate in neoplastic tissue within the irradiation volume; anticancer agents
05/01/2003US20030082192 Multidrug multiligand conjugates for targeted drug delivery
05/01/2003US20030082191 Treatment for central nervous system disorders
05/01/2003US20030082187 Combined cancer treatment methods using antibodies to aminophospholipids
05/01/2003US20030082172 Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
05/01/2003US20030082105 Selectively targeted fluorescent, radiolabeled, or fluorescent and radiolabeled compositions
05/01/2003US20030082103 Targeted therapeutic lipid constructs having cell surface targets
05/01/2003US20030082102 Reduces systemic toxicity and provides alternate treatments for tumor resistance or intolerance to cisplatinum
05/01/2003CA2464239A1 Psma antibodies and protein multimers
04/2003
04/30/2003CN1106860C Process for preparing iodine-125 seeds source carrier bar
04/29/2003US6554756 Method for manufacturing radioactive brachytherapy source material, brachytherapy source material and encapsulated radioactive brachytherapy source
04/26/2003WO2003035011A2 Multidrug multiligand conjugates for targeted drug delivery
04/26/2003CA2478543A1 Multidrug multiligand conjugates for targeted drug delivery
04/24/2003WO2003034068A1 Localization of disorders associated with kallikreins
04/24/2003WO2003033658A2 Neutrokine-alpha and neutrokine-alpha splice variant
04/24/2003WO2003033654A2 Direct targeting binding proteins
04/24/2003WO2003033648A2 Imaging the activity of extracellular proteases in cells using mutant anthrax toxin protective antigens that are cleaved by specific extracellular proteases
04/24/2003WO2003033497A1 Tetracyclic azaindoles and -indolines having serotonin 5-ht2c activity
04/24/2003WO2003033030A1 Pacap compositions and methods for tumor imaging and therapy
04/24/2003WO2003032902A2 Tumor targeted photodiagnostic-phototherapeutic agents
04/24/2003WO2003032899A2 Methods and materials for targeting and affecting selected cells
04/24/2003WO2003002489A3 Solid-phase electrophilic fluorination
04/24/2003WO2002079429A3 Anti-muc-1 single chain antibodies for tumor targeting
04/24/2003US20030078371 Glycopeptide for use in the prevention and treatment of bacterial infections
04/24/2003US20030078237 Treatment of a central nervous system disorders
04/24/2003US20030077693 Use of p97 and iron binding proteins as diagnostic and therapeutic agents
04/24/2003US20030077676 Anti-MUC-1 single chain antibodies for tumor targeting
04/24/2003US20030077675 Diagnosing gastrointestinal tumors in humans; obtain gastric tissue sample, incubate with preferential monoclonal antibody, detect reactivity, reactivity indicates gastrointestinal disorders
04/24/2003US20030077317 Drug delivery; adhesion to mucous membranes; biopolymer
04/24/2003US20030077280 Monoclonal antibody which specifically recognizes and forms complex with protein located on surface of activated T cells and thereby inhibits T cell activation of B cells
04/24/2003CA2476675A1 Neutrokine-alpha and neutrokine-alpha splice variant
04/24/2003CA2464412A1 Tetracyclic azaindoles and -indolines having serotonin 5-ht2cactivity
04/24/2003CA2463911A1 Tumor targeted photodiagnostic-phototherapeutic agents
04/24/2003CA2463898A1 Methods and materials for targeting and affecting selected cells
04/24/2003CA2463672A1 Direct targeting binding proteins
04/23/2003EP1304125A2 Diagnostic agent for liver function
04/23/2003EP1304124A1 Diagnostic agent for diabetes comprising 13C labelled compound
04/23/2003EP1303510A2 Cyclic oxyguanidine pyrazinones as protease inhibitors
04/23/2003EP1303312A2 Diagnosis of liver disease
04/23/2003EP1303311A2 Amyloid targeting imaging agents and uses thereof
04/23/2003EP1114046B1 Interleukin-5 inhibiting 6-azauracil derivatives
04/23/2003EP1017318A4 Method of imaging cell death in vivo
04/23/2003CN1413206A Non peptide tachykinin receptor antagonists
04/23/2003CN1413197A 4-phenyl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin
04/23/2003CA2403307A1 Substituted 2-cyclohexyl-4-phenyl-1h-imidazole derivatives
04/22/2003US6552089 Method of treating or preventing alopecia
04/22/2003US6551822 NL4 tie ligand homologue
04/22/2003US6551588 Administering at or around the solid tumor an expressible nucleic acid encoding interleukin-3, and providing a tumor antigen, then treating the tumor with radiotherapy
04/22/2003US6551574 Tuftsin receptor-specific peptides, peptidomimetics and peptide-like constructs for use in biological, pharmaceutical and radiopharmaceutical applications, in which peptide is conformationally fixed on complexation with metal ion
04/22/2003CA2113995C Use of gentisic acid or gentisyl alcohol for stabilising radiolabeled peptides and proteins
04/17/2003WO2003031452A2 4-haloethenylphenyl tropane:serotonin transporter imaging agents
04/17/2003WO2003030901A1 Arylsulphonyl-substituted tetrahydro- and hexahydro-carbazoles as 5-ht-6 receptor ligands
04/17/2003WO2003030879A1 Particle immobilized coatings and uses thereof
04/17/2003WO2003000271A3 System and method for the large scale labeling of compounds with radiohalogens
04/17/2003WO2002072636A3 Crystals of whole antibodies and fragments thereof and methods for making and using them
04/17/2003WO2002018576A3 Compositions and methods relating to lung specific genes
04/17/2003US20030073878 Radioactive seed with multiple markers and method for using same
04/17/2003US20030073716 Therapy for drug abruse; side effect reduction
04/17/2003US20030073702 Cyclic oxyguanidine pyrazinones as protease inhibitors
04/17/2003US20030073617 Antitumor, anticancer agents; rheumatic diseases; autoimmune diseases
04/17/2003US20030073615 Antitumor, anticancer agents; rheumatic diseases; autoimmune diseases
04/17/2003US20030072763 Absorb in the low- energy, ultraviolet, visible, or near-infrared (NIR) region of the electromagnetic spectrum that are used for the phototherapy of tumors and other lesions
04/17/2003US20030072709 Such as methionine and radiolabelled somatostatin receptor-binding peptide depreotide; for increasing shelf-life/storage stability; medical diagnosis
1 ... 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 ... 243